Search Results for "Dako Denmark"
Original Source: Dako Denmark A/S
Dako is one of the world's leading companies in cancer diagnostics. We are devoted to helping pathologists by improving their ability to diagnose cancer. To do this, we develop, manufacture and market cell-based cancer diagnostics for both clinical diagnostics and research use.The number of people suffering from cancer is constantly increasing. A key factor in ensuring patients the best treatment is to make an accurate diagnosis at an early stage. Dako’s products help doctors all over the world to make mo...
Matching Channels
None
Matching News
GLOSTRUP, Denmark, Jan. 7, 2013 - Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Eli Lilly and Company for the development of companio...
Dako, Panagene sign supply agreement for PNA oligomer component
Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako's diagnostic or research products. Dako, an Agilent Technolog...
GLOSTRUP, DENMARK -- (Marketwire) -- 03/05/13 -- Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, announced today it has received approval from the U.S. Food and Dr...
Dako enters collaboration with Eli Lilly and Company for development of companion diagnostics
GLOSTRUP, Denmark, Jan. 7, 2013 - Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Eli Lilly and Company for the development of companion...
Dako to Collaborate With Pfizer on Companion Diagnostics
GLOSTRUP, DENMARK -- (Marketwire) -- 02/12/13 -- Dako, an Agilent Technologies company, announced today it has entered into a collaboration agreement with Pfizer in the field of companion diagnostics...
Dako, a world leading provider of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest(TM) and HER2 FISH pharmDx(TM) Kit as companion diag...
Panagene Signs Off with Dako to Supply PNA Oligomer Component
Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako’s diagnostic or research products. Dak...
Dako to Offer New Antibody in U.S. to Diagnose Breast Cancer
GLOSTRUP, DENMARK -- (Marketwired) -- 04/03/13 -- Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, recently received clearance from the U.S. Food and Drug Administr...
Matching PubMed Articles
Influence of the VKORC1 3730 G > A polymorphism on warfarin dose.
Improved access to temporary pacing in Denmark.
The aim was to illustrate current use of temporary pacing (TP) in Denmark by replicating a questionnaire study from 1986 and to compare the results of the two studies.
Acute macular neuroretinopathy in relation to anti-thymocyte globulin infusion.
